Oral Drug Delivery Market - Forecasts from 2019 to 2024

March 2019 | 112 pages | ID: O927B90DA00EN
Knowledge Sourcing Intelligence LLP

Abstracts

The Oral drug delivery market is projected to grow at a CAGR of 6.99% to reach US$150.063 billion by 2024, from US$100.050 billion in 2018. Oral drug delivery is referred to the transfer of drug into the human body through an oral route of administration. This is considered as the most convenient route of administration and is preferred widely among a wide range of consumers. These are in high demand due to the prevalence of chronic diseases worldwide. Furthermore, rising R&D investment, growing health expenditure and a growing geriatric population is further driving the market growth during the forecast period.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the Oral drug delivery value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the oral drug delivery market.

Major industry players profiled as part of the report are Pfizer Inc., AstraZeneca, Alpex Pharma S.A., and SPI Pharma among others.

Segmentation

The oral drug delivery market has been analyzed through following segments:

By Formulation
Tablets
Capsules
Drops
Powder
Liquid or Syrup
Decoction

By Application
Disease Treatment
Research/Academic purposes

By Geography
North America
USA
Canada
Mexico
Others

South America
Brazil
Argentina
Others

Europe
Germany
France
United Kingdom
Spain
Others

Middle East and Africa
Saudi Arabia
Israel
Others

Asia Pacific
China
Japan
South Korea
India
Others

Contents

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Design
2.2. Secondary Sources

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Force Analysis
  4.5.1. Bargaining Power of Suppliers
  4.5.2. Bargaining Power of Buyers
  4.5.3. Threat of New Entrants
  4.5.4. Threat of Substitutes
  4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness

5. ORAL DRUG DELIVERY MARKET BY FORMULATION

5.1. Tablets
5.2. Capsules
5.3. Drops
5.4. Powder
5.5. Liquid or Syrup
5.6. Decoction

6. ORAL DRUG DELIVERY MARKET BY APPLICATION

6.1. Disease Treatment
6.2. Research/Academic purposes

7. ORAL DRUG DELIVERY MARKET BY GEOGRAPHY

7.1. North America
  7.1.1. USA
  7.1.2. Canada
  7.1.3. Mexico
  7.1.4. Others
7.2. South America
  7.2.1. Brazil
  7.2.2. Argentina
  7.2.3. Others
7.3. Europe
  7.3.1. Germany
  7.3.2. France
  7.3.3. United Kingdom
  7.3.4. Spain
  7.3.5. Others
7.4. Middle East and Africa
  7.4.1. Saudi Arabia
  7.4.2. Israel
  7.4.3. Others
7.5. Asia Pacific
  7.5.1. China
  7.5.2. Japan
  7.5.3. South Korea
  7.5.4. India
  7.5.5. Others

8. COMPETITIVE INTELLIGENCE

8.1. Competitive Benchmarking and Analysis
8.2. Recent Investment and Deals
8.3. Strategies of Key Players

9. COMPANY PROFILES

9.1. Pfizer Inc.
9.2. AstraZeneca
9.3. Alpex Pharma S.A.
9.4. SPI Pharma
9.5. Globela Pharma Pvt Ltd
9.6. Lupin Pharmaceuticals, Inc.
9.7. Bayer AG
9.8. Mayne Pharma Group Limited
LIST OF FIGURES
LIST OF TABLES